94 related articles for article (PubMed ID: 20850365)
1. Performance of quantitative ultrasound measurements of bone for monitoring raloxifene therapy.
Paggiosi MA; Clowes JA; Finigan J; Naylor KE; Peel NF; Eastell R
J Clin Densitom; 2010; 13(4):441-50. PubMed ID: 20850365
[TBL] [Abstract][Full Text] [Related]
2. Contact quantitative ultrasound: an evaluation of precision, fracture discrimination, age-related bone loss and applicability of the WHO criteria.
Frost ML; Blake GM; Fogelman I
Osteoporos Int; 1999; 10(6):441-9. PubMed ID: 10663343
[TBL] [Abstract][Full Text] [Related]
3. QUS in monitoring raloxifene and estrogen-progestogens: a 4-year longitudinal study.
Agostinelli D; de Terlizzi F
Ultrasound Med Biol; 2007 Aug; 33(8):1184-90. PubMed ID: 17467152
[TBL] [Abstract][Full Text] [Related]
4. Performance of five phalangeal QUS parameters in the evaluation of gonadal-status, age and vertebral fracture risk compared with DXA.
Albanese CV; Cepollaro C; de Terlizzi F; Brandi ML; Passariello R
Ultrasound Med Biol; 2009 Apr; 35(4):537-44. PubMed ID: 19097682
[TBL] [Abstract][Full Text] [Related]
5. Teriparatide's effects on quantitative ultrasound parameters and bone density in women with established osteoporosis.
Gonnelli S; Martini G; Caffarelli C; Salvadori S; Cadirni A; Montagnani A; Nuti R
Osteoporos Int; 2006 Oct; 17(10):1524-31. PubMed ID: 16767526
[TBL] [Abstract][Full Text] [Related]
6. Treatment with raloxifene for 2 years increases vertebral bone mineral density as measured by volumetric quantitative computed tomography.
Genant HK; Lang T; Fuerst T; Pinette KV; Zhou C; Thiebaud D; Diez-Perez A
Bone; 2004 Nov; 35(5):1164-8. PubMed ID: 15542042
[TBL] [Abstract][Full Text] [Related]
7. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy.
Sarkar S; Mitlak BH; Wong M; Stock JL; Black DM; Harper KD
J Bone Miner Res; 2002 Jan; 17(1):1-10. PubMed ID: 11771654
[TBL] [Abstract][Full Text] [Related]
8. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.
Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harper K
Chin Med J (Engl); 2004 Jul; 117(7):1029-35. PubMed ID: 15265377
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the longitudinal changes in quantitative ultrasound with dual-energy X-ray absorptiometry: the four-year effects of hormone replacement therapy.
Sahota O; San P; Cawte SA; Pearson D; Hosking DJ
Osteoporos Int; 2000; 11(1):52-8. PubMed ID: 10663359
[TBL] [Abstract][Full Text] [Related]
10. Does quantitative ultrasound imaging enhance precision and discrimination?
Frost ML; Blake GM; Fogelman I
Osteoporos Int; 2000; 11(5):425-33. PubMed ID: 10912845
[TBL] [Abstract][Full Text] [Related]
11. Quantitative ultrasound and symptomatic vertebral fracture risk in Chinese women.
Kung AW; Luk KD; Chu LW; Tang GW
Osteoporos Int; 1999; 10(6):456-61. PubMed ID: 10663345
[TBL] [Abstract][Full Text] [Related]
12. Palangeal quantitative ultrasound, phalangeal morphometric variables, and vertebral fracture discrimination.
Guglielmi G; Njeh CF; de Terlizzi F; De Serio DA; Scillitani A; Cammisa M; Fan B; Lu Y; Genant HK
Calcif Tissue Int; 2003 Apr; 72(4):469-77. PubMed ID: 12574870
[TBL] [Abstract][Full Text] [Related]
13. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harpe K
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):269-73. PubMed ID: 15059505
[TBL] [Abstract][Full Text] [Related]
14. Comparison of quantitative ultrasound of the phalanges with conventional bone densitometry in healthy postmenopausal women.
Alexandersen P; de Terlizzi F; Tankó LB; Bagger YZ; Christiansen C
Osteoporos Int; 2005 Sep; 16(9):1071-8. PubMed ID: 15719153
[TBL] [Abstract][Full Text] [Related]
15. Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women.
Atteritano M; Mazzaferro S; Frisina A; Cannata ML; Bitto A; D'Anna R; Squadrito F; Macrì I; Frisina N; Buemi M
Osteoporos Int; 2009 Nov; 20(11):1947-54. PubMed ID: 19238303
[TBL] [Abstract][Full Text] [Related]
16. Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosis.
Adami S; San Martin J; Muñoz-Torres M; Econs MJ; Xie L; Dalsky GP; McClung M; Felsenberg D; Brown JP; Brandi ML; Sipos A
Osteoporos Int; 2008 Jan; 19(1):87-94. PubMed ID: 17938984
[TBL] [Abstract][Full Text] [Related]
17. Quantitative bone ultrasound at phalanges and calcaneus in osteoporotic postmenopausal women: influence of age and measurement site.
Camozzi V; De Terlizzi F; Zangari M; Luisetto G
Ultrasound Med Biol; 2007 Jul; 33(7):1039-45. PubMed ID: 17445968
[TBL] [Abstract][Full Text] [Related]
18. Heel ultrasonography in monitoring alendronate therapy: a four-year longitudinal study.
Gonnelli S; Cepollaro C; Montagnani A; Martini S; Gennari L; Mangeri M; Gennari C
Osteoporos Int; 2002 May; 13(5):415-21. PubMed ID: 12086353
[TBL] [Abstract][Full Text] [Related]
19. Does the combination of quantitative ultrasound and dual-energy X-ray absorptiometry improve fracture discrimination?
Frost ML; Blake GM; Fogelman I
Osteoporos Int; 2001; 12(6):471-7. PubMed ID: 11446563
[TBL] [Abstract][Full Text] [Related]
20. Quantitative ultrasound of the tibia depends on both cortical density and thickness.
Prevrhal S; Fuerst T; Fan B; Njeh C; Hans D; Uffmann M; Srivastav S; Genant HK
Osteoporos Int; 2001; 12(1):28-34. PubMed ID: 11305080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
